| Code | Headline | Release Date |
|---|---|---|
TLZ |
30060 SIM Removal from Official List - Company Delisted - 12th of May 2015 Company Delisted - 12th of May 2015 |
12-May-2015 2:51:34 PM |
TLZ |
30050 SIM Suspension from Official Quotation - Continued Suspension - Company failed to lodge Half Yearly Report for 31 December 2014 Continued Suspension - Company failed to lodge Half Yearly Report for 31 December 2014 |
17-Mar-2015 9:56:44 AM |
TLZ |
30050 SIM Suspension from Official Quotation - Company placed under External Administration Company placed under External Administration |
18-Feb-2015 3:49:35 PM |
TLZ |
31999 SIM General Market Disclosure Other - Telezon's Unique & Valuable Patent Portfolio Continues to Grow Telezon's Unique & Valuable Patent Portfolio Continues to Grow |
24-Nov-2014 11:12:36 AM |
TLZ |
30930 SIM Results of Meeting - 2014 Annual General Meeting Results 2014 Annual General Meeting Results |
19-Nov-2014 4:05:03 PM |
TLZ |
30510 SIM Annual Report - TLZ Annual Report 2014 TLZ Annual Report 2014 |
29-Oct-2014 9:58:09 PM |
TLZ |
30910 SIM Notice of Annual General Meeting - TLZ AGM 2014 - Proxy TLZ AGM 2014 - Proxy |
22-Oct-2014 4:02:57 PM |
TLZ |
30910 SIM Notice of Annual General Meeting - TLZ AGM NOM 2014 TLZ AGM NOM 2014 |
22-Oct-2014 3:52:45 PM |
TLZ |
30399 SIM Issued Capital Other - Annexure 2A/3B-300k Unquoted Options Issue Annexure 2A/3B-300k Unquoted Options Issue |
26-Sep-2014 12:59:11 PM |
TLZ |
30530 SIM Preliminary/Final Statement - TLZ Annexure 3A for year ended 30 June 2014 TLZ Annexure 3A for year ended 30 June 2014 |
12-Sep-2014 9:28:54 AM |
TLZ |
30530 SIM Preliminary/Final Statement - TLZ Financial Report for year ended 30 June 2014 TLZ Financial Report for year ended 30 June 2014 |
12-Sep-2014 9:27:46 AM |
TLZ |
30399 SIM Issued Capital Other - Annexure 2A/3B - 300k Unquoted Options issue Annexure 2A/3B - 300k Unquoted Options issue |
10-Apr-2014 5:23:12 PM |
TLZPrice Sensitive |
31999 SIM General Market Disclosure Other - Supply Agreement Signed Between Wolfe Tory Medical & Telezon Ltd The Board of Telezon® Ltd is pleased to announce that Wolfe Tory Medial Inc., a Teleflex Inc. company, has approved Telezon for supply of SoloFlow® cannula. |
01-Apr-2014 12:41:22 PM |
TLZPrice Sensitive |
31999 SIM General Market Disclosure Other - Serum Institute of India Boosts Its SoloFlow® Stock 950,000 SoloFlow® Needles ordered by Serum Institute of India – the third order for SII |
25-Mar-2014 12:56:22 PM |
TLZPrice Sensitive |
30540 SIM Half Yearly Report - Annexure 3A: Half-Yearly Disclosure Annexure 3A: Half-Yearly Disclosure |
12-Mar-2014 3:22:12 PM |
TLZPrice Sensitive |
30550 SIM Half Yearly Report Audit Review - TLZ Half-Year Financial Report for half-year ended 31 December 2013 Half-Year Financial Report for half-year ended 31 December 2013 |
12-Mar-2014 3:20:07 PM |
TLZ |
31999 SIM General Market Disclosure Other - Telezon awarded Technology Development Voucher Telezon awarded Technology Development voucher worth $35,532 by Victorian Government |
14-Jan-2014 9:46:21 AM |
TLZ |
30380 SIM Exercise of Options - Annexure 2A & 3B - Expiry 1m Unquoted Options Annexure 2A & 3B - Expiry 1m Unquoted Options |
06-Jan-2014 4:51:53 PM |
TLZ |
30380 SIM Exercise of Options - Expiry of Unlisted Options Expiry of Unlisted Options: 31 Dec. 2013 |
06-Jan-2014 4:46:31 PM |
TLZ |
31999 SIM General Market Disclosure Other - Telezon Gains Exposure in Key Media Telezon Gains Exposure in Key Media |
11-Dec-2013 12:48:02 PM |
TLZ |
40399 SIM Issued Capital Other - Annexure 2A/3B - 3m Unquoted Options issue Annexure 2A/3B - notice that 3m Unquoted Options approved at AGM2013 for issue to Directors |
10-Dec-2013 1:44:01 PM |
TLZ |
40930 SIM Results of Meeting - 2013 Telezon AGM Results of Meeting 2013 Telezon AGM Results of Meeting |
28-Nov-2013 3:52:42 PM |
TLZ |
40910 SIM Notice of Annual General Meeting - AGM 2013 Notice of Meeting AGM 2013 Notice of Meeting |
29-Oct-2013 12:15:03 PM |
TLZ |
40510 SIM Annual Report - Annual Report 2013 Annual Report 2013 |
21-Oct-2013 5:24:28 PM |
TLZPrice Sensitive |
41999 SIM General Market Disclosure Other - SoloFlow® accepted by TGA SoloFlow® Non-Injection Needle accepted by TGA: can now be sold commercially in Australia. |
14-Oct-2013 12:32:54 PM |
TLZ |
41999 SIM General Market Disclosure Other - TLZ: Final SoloFlow® shipment to SII complete TLZ: Final SoloFlow® shipment of 300k units to SII complete |
09-Sep-2013 2:13:44 PM |
TLZ |
40530 SIM Preliminary/Final Statement - Consolidated Financial Report: 30 June 2013 Consolidated Financial Report: 30 June 2013 |
23-Aug-2013 4:57:24 PM |
TLZ |
40530 SIM Preliminary/Final Statement - Annexure 3A: Annual Disclosure Annexure 3A: Annual Disclosure |
23-Aug-2013 4:57:19 PM |
TLZ |
41999 SIM General Market Disclosure Other - Final Payment of Negotiated Commercial Settlement The Board of Telezon® Limited wishes to advise its Shareholders and the market that Telezon has advanced the final payment to Friedman Capital Pty Ltd under a commercial arrangement reached in May 2012. |
16-Aug-2013 11:31:12 AM |
TLZ |
40340 SIM Non Renounceable Issue - Annexure 2A/3B - Shortfall Annexure 2A/3B - Shortfall |
02-Aug-2013 5:00:40 PM |
TLZPrice Sensitive |
40340 SIM Non Renounceable Issue - Funds Raised in Shortfall Offer Funds Raised in Shortfall Offer |
25-Jul-2013 9:07:12 AM |
TLZ |
40120 SIM Change in Substantial Shareholder - Change of Interests of Substantial Holder - Iron Mountain Pty Ltd Change of Interests of Substantial Holder - Iron Mountain Pty Ltd |
09-Jul-2013 12:19:50 PM |
TLZ |
40340 SIM Non Renounceable Issue - Funds Raised in Rights Issue 2013 Funds Raised in Non Renounceable Rights Issue 2013 |
01-Jul-2013 11:18:53 AM |
TLZ |
40340 SIM Non Renounceable Issue - Annexure 2A/3B (amended): Rights Issue Annexure 2A/3B (amended): Rights Issue |
26-Jun-2013 4:44:34 PM |
TLZ |
40340 SIM Non Renounceable Issue - Annexure 2A/3B - Rights Issue Annexure 2A/3B: Issuance and/or Quotation of Additional Securities (pursuant to TLZ Non-Renounceable Rights Issue Offer) |
25-Jun-2013 10:48:08 AM |
TLZ |
41999 SIM General Market Disclosure Other - Telezon Director featured BioSpectrum Telezon Director featured BioSpectrum |
17-Jun-2013 11:26:46 AM |
TLZ |
40340 SIM Non Renounceable Issue - Telezon Rights Issue Extension Closing Date Telezon Rights Issue Extension Closing Date |
31-May-2013 5:10:08 PM |
TLZ |
40340 SIM Non Renounceable Issue - Notice of Despatch of Rights Issue Offer Document to Eligible Shareholders Notice of Despatch of Rights Issue Offer Document to Eligible Shareholders |
23-May-2013 6:49:07 AM |
TLZ |
40350 SIM Prospectus - Amended Rights Issue Offer Document Telezon Amended Rights Issue Offer Document |
15-May-2013 9:47:06 AM |
TLZ |
40340 SIM Non Renounceable Issue - Letter to Ineligible Shareholders Letter to Ineligible Shareholders regarding Non Renounceable Rights Issue |
13-May-2013 3:06:08 PM |
TLZ |
40340 SIM Non Renounceable Issue - Letter to Eligible Shareholders Letter to Eligible Shareholders regarding Non Renounceable Rights Issue |
13-May-2013 3:06:00 PM |
TLZPrice Sensitive |
41999 SIM General Market Disclosure Other - Second Shipment of SoloFlow® Commercial Order to Serum Institute of India The Board of Telezon is pleased to inform the market that the second of three shipments for the 500,000 SoloFlow® commercial order has been dispatched to Serum Institute of India. |
10-May-2013 2:29:44 PM |
TLZPrice Sensitive |
40350 SIM Prospectus - Rights Issue Offer Document Telezon''s Non Renounceable Rights Issue Offer Document |
09-May-2013 9:09:25 PM |
TLZ |
40340 SIM Non Renounceable Issue - Annexure 2A/3B - Rights Issue Annexure 2A/3B - Rights Issue May 2013 |
09-May-2013 4:12:49 PM |
TLZ |
40340 SIM Non Renounceable Issue - TLZ Non-Renounceable Rights Issue TLZ Non-Renounceable Rights Issue - May 2013 |
09-May-2013 4:07:21 PM |
TLZ |
40030 SIM Trading Halt - Company request for Trading Halt pending an announcement. Company request for Trading Halt pending an announcement. |
09-May-2013 9:06:38 AM |
TLZ |
41999 SIM General Market Disclosure Other - Telezon’s Unique & Valuable Family of Patents Continues to Grow The Board of Telezon Limited would like to report that the Japan Patent Office has issued a decision to grant a patent for SSB Technology’s `needle tip` invention |
08-Apr-2013 8:42:44 AM |
TLZ |
41999 SIM General Market Disclosure Other - SoloFlow® Outperforms Competitors in Recent ISO Test The Board of Telezon® is pleased to inform the market that the SoloFlow® needle has exceeded expectations in recent preliminary results, demonstrating that it does not generate any fragments after insertion into a vial rubber stopper. A typical steel hypodermic needle generated four times the number of fragments. |
05-Apr-2013 8:56:57 AM |
TLZ |
41999 SIM General Market Disclosure Other - First Shipment of SoloFlow® to Serum Institute of India The Board of Telezon is pleased to inform the market that the first of three shipments for the 500,000 SoloFlow® commercial order, has been dispatched to Serum Institute of India |
11-Mar-2013 9:15:54 AM |
TLZPrice Sensitive |
40550 SIM Half Yearly Report Audit Review - Half-Year Financial Report for half-year ended 31 December 2012 Telezon Ltd & Consolidated Entities Half-Year Financial Report for the half-year ended 31 December 2012 |
26-Feb-2013 8:18:03 PM |
TLZPrice Sensitive |
40540 SIM Half Yearly Report - Annexure 3A: Half-Yearly Disclosure Annexure 3A: Half-Yearly Disclosure for half-year ended 31 Dec 2012 |
26-Feb-2013 8:17:55 PM |
TLZ |
41999 SIM General Market Disclosure Other - Telezon recognised in BioSpectrum Asia article Biospectrum Asia Journal recognises Telezon''s presence in India |
22-Feb-2013 8:51:46 AM |
TLZ |
41999 SIM General Market Disclosure Other - Telezon Directors well-received in India Telezon representatives, products & technologies well-received in India, as part of Super Trade Mission with Victorian Government |
21-Feb-2013 6:47:35 AM |
TLZPrice Sensitive |
41999 SIM General Market Disclosure Other - SoloFlow® Successfully Completes the CE Mark Conformity Process The Board of Telezon® Limited (“the Company”) is pleased to advise the market that the Company’s flagship SoloFlow® Non Injection Needle has successfully completed all mandatory testing and validation for the CE Mark. |
17-Dec-2012 12:46:02 PM |
TLZ |
30930 SIM Results of Meeting - Telezon 2012 AGM Results of Meeting Telezon 2012 AGM Results of Meeting |
29-Nov-2012 4:01:56 PM |
TLZ |
31999 SIM General Market Disclosure Other - AGM 2012 Presentation Telezon AGM Presentation 2012 |
29-Nov-2012 9:23:29 AM |
TLZ |
30910 SIM Notice of Annual General Meeting - Notice of Meeting for AGM 2012 Notification of Telezon Annual General Meeting - 29 November 2012 |
31-Oct-2012 5:07:15 PM |
TLZ |
30510 SIM Annual Report - Annual Report 2012 Telezon Annual Report - 30 June 2012 |
31-Oct-2012 5:00:30 PM |
TLZ |
30530 SIM Preliminary/Final Statement - Amended Financial Report Amended Financial Report |
30-Oct-2012 7:38:30 PM |
TLZ |
31999 SIM General Market Disclosure Other - Activities Update – September/October 2012 Update of activities for September and October 2012 |
09-Oct-2012 8:51:36 AM |
TLZ |
30530 SIM Preliminary/Final Statement - Consolidated Financial Report: 30 June 2012 Audited Consolidated Financial Report for year end 30 June 2012 |
13-Sep-2012 12:49:06 PM |
TLZ |
30530 SIM Preliminary/Final Statement - Annexure 3A: Annual Disclosure Annual Disclosure of Full Year Financial Statements as at 30 June 2012. |
13-Sep-2012 12:48:23 PM |
TLZ |
31999 SIM General Market Disclosure Other - Prospectus Closed Prospectus closed below minimum subscription limit due to market conditions |
24-Aug-2012 8:51:05 AM |
TLZ |
40030 SIM Trading Halt - Company placed under a Trading Halt due to price sensitive announcement received. Company placed under a Trading Halt due to price sensitive announcement received. |
15-Aug-2012 10:36:09 AM |
TLZPrice Sensitive |
31999 SIM General Market Disclosure Other - Confidential MOU signed to obtain CE Mark (Europe) for SoloFlow® & Blunt SoloFlow® The Board of Telezon® is very pleased to announce that a MOU has been signed between SSB Technology/Telezon and a third party in a confidential agreement to undertake and obtain CE Marks for SoloFlow® and Blunt SoloFlow®. |
15-Aug-2012 10:36:26 AM |
TLZ |
31999 SIM General Market Disclosure Other - Updated Prospectus Timetable for Telezon’s Capital Raising The Board of Telezon has extended the Close of Offer to 21 August 2012 due to an overwhelming response and interest in it's capital raising. |
06-Aug-2012 8:46:03 AM |
TLZ |
41999 SIM General Market Disclosure Other - Telezon produces 14,500 Blunt SoloFlow® needle samples with CoreIT® Technology The Company is pleased to announce that two needle lengths for the Blunt SoloFlow® have been successfully produced using its unique CoreIT® moulding technology. |
20-Jul-2012 10:33:21 AM |
TLZ |
40930 SIM Results of Meeting - Telezon EGM Results 4 July 2012 Telezon EGM Results 4 July 2012 |
04-Jul-2012 3:45:00 PM |
TLZ |
41999 SIM General Market Disclosure Other - General Meeting Presentation 4 July 2012 General Meeting Presentation 4 July 2012 |
03-Jul-2012 4:30:03 PM |
TLZPrice Sensitive |
40030 SIM Trading Halt - Trading Halt - Market Sensitive Announcement Received Trading Halt - Market Sensitive Announcement Received |
03-Jul-2012 2:35:36 PM |
TLZPrice Sensitive |
41999 SIM General Market Disclosure Other - Serum Institute of India Orders 500,000 SoloFlow® Cannula The Board of Telezon® Limited is pleased to announce that the Serum Institute of India, the world’s largest producer of Measles and DTP vaccines, has placed a second commercial order for 500,000 SoloFlow® needles. |
03-Jul-2012 2:35:54 PM |
TLZPrice Sensitive |
40350 SIM Prospectus - Telezon Ltd Prospectus for Offer of Ordinary Shares and Options Prospectus for Offer of Ordinary Shares and Options |
08-Jun-2012 9:27:58 AM |
TLZ |
40920 SIM Notice of Extraordinary Meeting - Telezon Notice of Meeting 4 July 2012 General Meeting to be held on 4th July 2012 |
07-Jun-2012 8:25:28 AM |
TLZ |
41999 SIM General Market Disclosure Other - Settlement Negotiated between Telezon Ltd & Friedman Capital Pty Ltd The Board of Telezon® Limited wishes to advise the market and its Shareholders that Telezon and Friedman Capital Pty Ltd have reached a negotiated settlement and as a result, the proceedings against Friedman Capital have been discontinued. |
21-May-2012 8:59:18 AM |
TLZ |
40110 SIM Becoming a Substantial Shareholder - Form 603 - Notice of Initial Substantial Holder Notice of Initial Substantial Holder |
10-May-2012 7:38:15 PM |
TLZ |
40110 SIM Becoming a Substantial Shareholder - Form 603 - Notice of Initial Substantial Holder Notice of Initial Substantial Holder |
10-May-2012 7:37:55 PM |
TLZ |
40150 SIM Section 205G Notice Change in Director's Interests - Annexure 3D - Change of Director's Interest Notice Change of Director's Interest Notice for Ms Elaine Carr |
10-May-2012 7:37:36 PM |
TLZ |
40150 SIM Section 205G Notice Change in Director's Interests - Annexure 3D - Change of Director's Interest Notice Change of Director's Interest Notice for Dr Michelle Carr |
10-May-2012 7:37:16 PM |
TLZ |
40120 SIM Change in Substantial Shareholder - Notice of Change of Substantial Holder Change in Substantial Holder |
10-May-2012 7:36:58 PM |
TLZPrice Sensitive |
41999 SIM General Market Disclosure Other - Memorandum of Understanding to Sell & Supply SoloFlow® Cannula The Board of Telezon® Limited is pleased to announce that a Memorandum of Understanding has been signed between SSB Technology Pty Ltd (a wholly owned subsidiary of Telezon) and Hindustan Syringes and Medical Devices Ltd of India outlining a commercial agreement to sell and supply SoloFlow® needle for the Indian market. |
30-Apr-2012 9:14:20 AM |
TLZ |
41999 SIM General Market Disclosure Other - Marketing Samples Successfully Produced for BLUNT SoloFlow® Cannula Telezon Limited® (“the Company”) has further demonstrated the multiple application potential of its CoreIT® Technology in producing 5000 Blunt SoloFlow® marketing samples. |
28-Mar-2012 8:50:08 AM |
TLZ |
41999 SIM General Market Disclosure Other - Serum Institute of India's Clinical Trials Use SoloFlow® Cannula Serum Institute of India has confirmed that the Company’s SoloFlow® cannula will be used in one of their clinical trials for a new influenza vaccine later this year. |
13-Mar-2012 8:44:53 AM |
TLZ |
40110 SIM Becoming a Substantial Shareholder - Form 603 - Notice of Initial Substantial Holder Notice of Initial Substantial Holder |
08-Mar-2012 1:51:57 PM |
TLZ |
40550 SIM Half Yearly Report Audit Review - Half Year Financial Report Half Year Financial Report for half-year ended 31 December 2012 |
06-Mar-2012 8:22:43 AM |
TLZ |
40540 SIM Half Yearly Report - Annexure 3A - Half Yearly Disclosure Annexure 3A - Half Yearly Disclosure |
06-Mar-2012 8:22:21 AM |
TLZ |
40120 SIM Change in Substantial Shareholder - Form 604 - Change of Interests in Substantial Holder Notice of Change of Interests in Substantial Holder |
02-Mar-2012 3:28:44 PM |
TLZ |
40120 SIM Change in Substantial Shareholder - Form 604 - Change of Interests in Substantial Holder Notice of Change of Interests in Substantial Holder |
02-Mar-2012 3:28:26 PM |
TLZ |
40150 SIM Section 205G Notice Change in Director's Interests - Annexure 3D - Change of Director's Interest Notice Change of Director's Interest Notice for Ms Elaine Carr |
01-Mar-2012 11:18:32 AM |
TLZ |
40150 SIM Section 205G Notice Change in Director's Interests - Annexure 3D - Change of Director's Interest Notice Change of Director's Interest Notice for Dr Michelle Carr |
01-Mar-2012 11:18:50 AM |
TLZ |
40150 SIM Section 205G Notice Change in Director's Interests - Annexure 3D - Change of Director's Interest Notice Change of Director's Interest Notice for Mr Trevor Nye |
01-Mar-2012 11:19:41 AM |
TLZ |
40315 SIM Placement - Annexure 2A & 3B Issuance &/or Quotation of Additional 'TLZ' Securities Application. |
01-Mar-2012 10:48:07 AM |
TLZ |
40315 SIM Placement - Notice Under s708A Cleansing Statement The Company hereby gives notice pursuant to Section 708A(5)(e) of the Corporations Act and the provides the required information in relation to the issue of 6,256,000 fully paid ordinary shares. |
01-Mar-2012 10:47:49 AM |
TLZ |
40315 SIM Placement - Telezon Completes Private Placement Telezon has issued a total of 6,256,000 fully paid ordinary shares; 6,156,000 issued via placement at $0.11 per share to raise a total of $677,160; and 100,000 issued in accordance with a contractor agreement for nil consideration. The shares rank equally in all respects with the Company’s existing ordinary shares. The funds will be used to advance the Company’s needle technologies and for working capital purposes. |
01-Mar-2012 10:40:42 AM |
TLZ |
41999 SIM General Market Disclosure Other - 4-Fold Mould Produces Another Batch of SoloFlow® Telezon's 4-fold pre-production mould has successfully produced 25,000 SoloFlow® Medical Transfer Cannulae. |
09-Feb-2012 8:52:27 AM |
TLZ |
40315 SIM Placement - Details of Private Share Placement The Board wishes to further advise that the proposed private placement of up to 6,256,000 shares will be offered at an issue price of $0.11 to raise a maximum of $688,160 with allocation of securities to be effected no earlier than 1 March 2012. |
08-Feb-2012 5:07:50 PM |
TLZ |
40315 SIM Placement - Private Share Placement The Board of Telezon wishes to advise that it intends to effect a share placement to private investors. |
06-Feb-2012 7:27:37 PM |
TLZPrice Sensitive |
41999 SIM General Market Disclosure Other - SoloFlow® Shipped to India The Company's first commercial order of its SoloFlow® Medical Transfer Cannula has been shipped from its contract manufacturer to Serum Institute of India. |
30-Jan-2012 7:31:09 AM |
TLZPrice Sensitive |
41999 SIM General Market Disclosure Other - International Recognition by World Health Organisation for SoloFlow The World Health Organization (WHO) has recognised SoloFlow® Medical Transfer Cannula and its potential benefits in the Developing World. |
24-Jan-2012 8:15:23 AM |
TLZ |
41999 SIM General Market Disclosure Other - SoloFlow - Successful Completion of First Commercial Batch This first commercial batch is now ready for shipping to fulfill the initial order for Serum Institute of India for use in clinical trials. The Company is finalising required regulatory documentation in preparation for the first shipment due for dispatch in Week 4 of January 2012. |
23-Jan-2012 8:39:11 AM |
TLZ |
40020 SIM Commencement of Official Quotation - Commencement of Quotation - 1st of December 2011 Commencement of Quotation - 1st of December 2011 |
29-Nov-2011 2:35:58 PM |
TLZ |
40520 SIM Top 20 Shareholders - Top 20 Shareholders & Share Distribution Top 20 Shareholders & Share Distribution |
28-Nov-2011 2:31:06 PM |
TLZ |
40140 SIM Section 205G Notice Initial/Final Directors Interests - Initial Director's Interests Initial Directors Interests |
28-Nov-2011 2:29:28 PM |
TLZ |
40510 SIM Annual Report - Annual Report - 30 June 2011 Annual Report - 30 June 2011 |
28-Nov-2011 2:28:33 PM |
TLZ |
40510 SIM Annual Report - Annual Report - 30 June 2010 Annual Report - 30 June 2010 |
28-Nov-2011 2:27:44 PM |
TLZ |
40510 SIM Annual Report - Annual Report - 30 June 2009 Annual Report - 30 June 2009 |
28-Nov-2011 2:26:40 PM |
TLZ |
40022 SIM Articles of Association/Constitution - Constitution Constitution |
28-Nov-2011 2:25:14 PM |
TLZ |
40099 SIM Official List Other - Information Memorandum Information Memorandum |
28-Nov-2011 2:24:04 PM |
TLZ |
40099 SIM Official List Other - Application to List Application to List |
28-Nov-2011 2:22:55 PM |